Literature DB >> 6193076

Conformational study of the neurotensin and substance P fragments: Pro-Arg-Arg-Pro and Arg-Pro-Lys-Pro.

M Cotrait.   

Abstract

The conformational behaviour of the basic hydrophilic Pro-Arg-Arg-Pro and Arg-Pro-Lys-Pro peptides, neurotensin (NT) and Substance P fragments, has been taken up by semi-empirical calculations. The presence of two Pro residues prevents these peptides from giving any folded structure (alpha helix, beta turn . . .). In both peptides the most stable conformations are essentially relative to more or less stretched structures; structures involving one or more residues in a gamma turn form are often encountered in Pro-Arg-Arg-Pro peptide while mixed structures involving residues in very different conformations are found for the Arg-Pro-Lys-Pro-peptide. In both peptides, positively charged Lys and Arg side-chains most often point in opposite directions. The Pro-Arg-Arg-Pro peptide is part of the active NT (7-13) fragment where both Arg residues are necessary to the activity. A tentative study shows that the hydrophilic tetrapeptide induces NT (7-13) stretched conformations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193076     DOI: 10.1111/j.1399-3011.1983.tb02074.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  3 in total

1.  Computational simulations of the conformational behaviour of the adhesive proteins RGDS fragment.

Authors:  M Cotrait; M Kreissler; J Hoflack; J M Lehn; B Maigret
Journal:  J Comput Aided Mol Des       Date:  1992-04       Impact factor: 3.686

2.  Computer simulation of the conformational behaviour of angiotensinogen (6-13) renin substrate.

Authors:  M Benkoulouche; M Cotrait; B Maigret
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

3.  Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonist.

Authors:  Y P Pang; J Zaidi; A P Kozikowski; B Cusack; E Richelson
Journal:  J Comput Aided Mol Des       Date:  1994-08       Impact factor: 3.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.